ARTICLE | Clinical News
BromSite regulatory update
June 15, 2015 7:00 AM UTC
InSite submitted an NDA to FDA for BromSite to treat inflammation and prevent pain in cataract surgery. BromSite is low-dose bromfenac, an NSAID, delivered via InSite’s DuraSite sustained delivery tec...